Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants

NCT00879827 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Poliomyelitis
Hepatitis B
Tetanus
Acellular Pertussis

Interventions

BIOLOGICAL: Pediarix TM, Infanrix penta TM
BIOLOGICAL: Hiberix TM

Sponsor

GlaxoSmithKline